MAGE-1 (161-169)

MAGE-1 (161-169) is a synthetic peptide fragment derived from the melanoma-associated antigen 1 (MAGE-1) protein, specifically encompassing amino acids 161 to 169 of the native sequence. As a well-characterized epitope, it plays a significant role in immunological research, particularly in the study of tumor antigens and antigen-specific T cell responses. The peptide's defined sequence and immunogenic profile make it a valuable tool for dissecting cellular immune mechanisms, supporting the development of antigen presentation assays, and enabling functional investigations into the molecular interactions underlying cancer immunology. Its application extends across various research domains that require precise peptide-based reagents for experimental reproducibility and mechanistic insight.

Epitope Mapping: Researchers utilize this peptide in epitope mapping studies to identify and characterize the specific regions of the MAGE-1 protein recognized by cytotoxic T lymphocytes (CTLs). By employing the 161-169 sequence in in vitro assays, scientists can dissect T cell receptor specificity and determine which immune cell subsets are activated by the antigen. Such studies provide foundational knowledge for understanding immune recognition and for identifying immunodominant epitopes relevant to tumor immunology.

Antigen Presentation Assays: The MAGE-1 (161-169) peptide is widely used in antigen presentation experiments to evaluate the functional capacity of major histocompatibility complex (MHC) class I molecules to present tumor-associated antigens. By pulsing antigen-presenting cells (APCs) with the peptide, investigators can measure peptide-MHC complex formation, assess the efficiency of antigen processing pathways, and quantify T cell activation responses. These assays are essential for elucidating the mechanisms of immune surveillance and for optimizing antigen delivery strategies in basic research.

T Cell Activation and Functional Studies: In immunological research, this peptide serves as a defined stimulus for the activation and expansion of antigen-specific CD8+ T cells. By providing a known target, it enables the evaluation of T cell cytotoxicity, cytokine secretion profiles, and proliferative responses in various experimental systems. These studies are critical for advancing the understanding of adaptive immunity and for developing peptide-based immunological assays.

Peptide-Based Assay Development: Due to its sequence specificity and immunological relevance, the MAGE-1 (161-169) peptide is incorporated into the design of peptide-based assays such as ELISPOT, flow cytometry, and enzyme-linked immunosorbent assays (ELISA). These platforms leverage the peptide's properties to detect and quantify antigen-specific T cell responses, facilitating high-throughput screening and comparative studies of immune function. Such assays are instrumental in both basic research and translational applications where precise measurement of immune reactivity is required.

Peptide Synthesis and Structure-Activity Studies: The defined structure of this peptide allows for its use as a model system in peptide synthesis optimization and structure-activity relationship (SAR) investigations. Researchers may modify the sequence or introduce analogs to probe the influence of specific amino acid residues on antigenicity, MHC binding affinity, or stability. These studies inform the rational design of improved peptide reagents and contribute to the broader field of synthetic peptide chemistry.

By supporting a range of applications from immunological assay development to fundamental studies of antigen recognition and peptide engineering, the MAGE-1 (161-169) peptide occupies a central role in peptide-based research. Its use enables detailed mechanistic insights and methodological advancements in the study of tumor antigens and immune system function.

1. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Cationic cell-penetrating peptides are potent furin inhibitors